世界の第IX因子欠乏症治療市場2020:企業別、地域別、種類別、用途別、市場予測2025

GlobalInfoResearchが発行した調査報告書(GIR20OC05343)
◆英語タイトル:Global Factor IX Deficiency Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20OC05343
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年10月(※2024年版があります。お問い合わせください。)
◆ページ数:102
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本書では、第IX因子欠乏症治療の世界市場を調査対象にし、第IX因子欠乏症治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(血友病B、血友病B阻害剤)、用途別分析(病院、診療所、その他)、市場予測(2021年~2025年)情報などを整理しました。
・市場概要
・企業情報:Pfizer、Biogen、Takeda、Novo Nordisk、CSL Behring
・企業別売上、市場シェア
・第IX因子欠乏症治療の地域別市場分析
・第IX因子欠乏症治療の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・第IX因子欠乏症治療のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・第IX因子欠乏症治療のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・第IX因子欠乏症治療の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・第IX因子欠乏症治療の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・第IX因子欠乏症治療の種類別市場規模2015-2020:血友病B、血友病B阻害剤
・第IX因子欠乏症治療の用途別市場規模2015-2020:病院、診療所、その他
・第IX因子欠乏症治療の世界市場予測2021-2025:地域別、種類別、用途別
・調査の結果・結論
【レポートの概要】

Market Overview
The global Factor IX Deficiency Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Factor IX Deficiency Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Factor IX Deficiency Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Factor IX Deficiency Treatment market has been segmented into:
Hemophilia B
Hemophilia B Inhibitors

By Application, Factor IX Deficiency Treatment has been segmented into:
Hospitals
Clinics
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Factor IX Deficiency Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Factor IX Deficiency Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Factor IX Deficiency Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Factor IX Deficiency Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Factor IX Deficiency Treatment Market Share Analysis
Factor IX Deficiency Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Factor IX Deficiency Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Factor IX Deficiency Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Factor IX Deficiency Treatment are:
Pfizer
Biogen
Takeda
Novo Nordisk
CSL Behring

【レポートの目次】

Table of Contents

1 Factor IX Deficiency Treatment Market Overview
1.1 Product Overview and Scope of Factor IX Deficiency Treatment
1.2 Classification of Factor IX Deficiency Treatment by Type
1.2.1 Global Factor IX Deficiency Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Factor IX Deficiency Treatment Revenue Market Share by Type in 2019
1.2.3 Hemophilia B
1.2.4 Hemophilia B Inhibitors
1.3 Global Factor IX Deficiency Treatment Market by Application
1.3.1 Overview: Global Factor IX Deficiency Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Factor IX Deficiency Treatment Market by Regions
1.4.1 Global Factor IX Deficiency Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Factor IX Deficiency Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Factor IX Deficiency Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Factor IX Deficiency Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Factor IX Deficiency Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Factor IX Deficiency Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Factor IX Deficiency Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Factor IX Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Biogen
2.2.1 Biogen Details
2.2.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Biogen SWOT Analysis
2.2.4 Biogen Product and Services
2.2.5 Biogen Factor IX Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Takeda
2.3.1 Takeda Details
2.3.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Takeda SWOT Analysis
2.3.4 Takeda Product and Services
2.3.5 Takeda Factor IX Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novo Nordisk
2.4.1 Novo Nordisk Details
2.4.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novo Nordisk SWOT Analysis
2.4.4 Novo Nordisk Product and Services
2.4.5 Novo Nordisk Factor IX Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 CSL Behring
2.5.1 CSL Behring Details
2.5.2 CSL Behring Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 CSL Behring SWOT Analysis
2.5.4 CSL Behring Product and Services
2.5.5 CSL Behring Factor IX Deficiency Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Factor IX Deficiency Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Factor IX Deficiency Treatment Players Market Share
3.2.2 Top 10 Factor IX Deficiency Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Factor IX Deficiency Treatment Revenue and Market Share by Regions
4.2 North America Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
5 North America Factor IX Deficiency Treatment Revenue by Countries
5.1 North America Factor IX Deficiency Treatment Revenue by Countries (2015-2020)
5.2 USA Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
6 Europe Factor IX Deficiency Treatment Revenue by Countries
6.1 Europe Factor IX Deficiency Treatment Revenue by Countries (2015-2020)
6.2 Germany Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
6.4 France Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Factor IX Deficiency Treatment Revenue by Countries
7.1 Asia-Pacific Factor IX Deficiency Treatment Revenue by Countries (2015-2020)
7.2 China Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
7.5 India Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
8 South America Factor IX Deficiency Treatment Revenue by Countries
8.1 South America Factor IX Deficiency Treatment Revenue by Countries (2015-2020)
8.2 Brazil Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Factor IX Deficiency Treatment by Countries
9.1 Middle East & Africa Factor IX Deficiency Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Factor IX Deficiency Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Factor IX Deficiency Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Factor IX Deficiency Treatment Market Forecast by Type (2019-2024)
10.3 Hemophilia B Revenue Growth Rate (2015-2025)
10.4 Hemophilia B Inhibitors Revenue Growth Rate (2015-2025)
11 Global Factor IX Deficiency Treatment Market Segment by Application
11.1 Global Factor IX Deficiency Treatment Revenue Market Share by Application (2015-2020)
11.2 Factor IX Deficiency Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Factor IX Deficiency Treatment Market Size Forecast (2021-2025)
12.1 Global Factor IX Deficiency Treatment Market Size Forecast (2021-2025)
12.2 Global Factor IX Deficiency Treatment Market Forecast by Regions (2021-2025)
12.3 North America Factor IX Deficiency Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Factor IX Deficiency Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Factor IX Deficiency Treatment Revenue Market Forecast (2021-2025)
12.6 South America Factor IX Deficiency Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Factor IX Deficiency Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の第IX因子欠乏症治療市場2020:企業別、地域別、種類別、用途別、市場予測2025(Global Factor IX Deficiency Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。